Arteriosclerosis, Thrombosis, and Vascular Biology. 1989;9:237-241
Arteriosclerosis, Vol 9, 237-241, Copyright © 1989 by American Heart Association
ARTICLES |
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients
T Kuusi, MS Nieminen, C Ehnholm, H Yki-Jarvinen, M Valle, EA Nikkila and MR Taskinen
First Department of Medicine, University of Helsinki, Finland.
Several studies have indicated that genetic polymorphism of apolipoprotein (apo) E is related to coronary artery disease (CAD). We therefore determined the apo E phenotype in 91 consecutive Finnish men with angiographically confirmed CAD. The apo E phenotype distribution differed significantly from that observed in the Finnish population (p less than 0.05). In the patient group, the frequency of the epsilon 4 allele was 0.324, which is 1.4-fold higher than in the normal Finnish population and twice as high as in other Caucasian populations. Serum lipoproteins and postheparin plasma lipase activities did not display any significant variation according to apo E phenotype. These studies confirm and extend, in a population with high epsilon 4 allele frequency, the previous data on the impact of the epsilon 4 allele on the risk of CAD and suggest that the high epsilon 4 allele frequency in the Finnish population may be one factor contributing to Finns' increased susceptibility to CAD.
This article has been cited by other articles:
 |
|
 |
|
  A. M. Bennet, E. Di Angelantonio, Z. Ye, F. Wensley, A. Dahlin, A. Ahlbom, B. Keavney, R. Collins, B. Wiman, U. de Faire, et al. Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk JAMA, September 19, 2007; 298(11): 1300 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification Endocr. Rev., August 1, 2004; 25(4): 629 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Song, M. J. Stampfer, and S. Liu Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease Ann Intern Med, July 20, 2004; 141(2): 137 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Doherty, L. A. Fitzpatrick, A. Shaheen, T. B. Rajavashisth, and R. C. Detrano Genetic Determinants of Arterial Calcification Associated With Atherosclerosis Mayo Clin. Proc., February 1, 2004; 79(2): 197 - 210. [Abstract] [PDF]
|
|
|
|
 |
|
 P. G Kehoe Review: The renin-angiotensin-aldosterone system and Alzheimer's disease? Journal of Renin-Angiotensin-Aldosterone System, June 1, 2003; 4(2): 80 - 93. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Kolovou, D. Daskalova, and D. P. Mikhailidis Apolipoprotein E Polymorphism and Atherosclerosis Angiology, January 1, 2003; 54(1): 59 - 71. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Lehtimaki, P. Dastidar, H. Jokela, T. Koivula, S. Lehtinen, C. Ehnholm, and R. Punnonen Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Functional Apolipoprotein E Genotype J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4147 - 4153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Bernstein, M. C. Costanza, R. W. James, M. A. Morris, F. Cambien, S. Raoux, and A. Morabia Physical Activity May Modulate Effects of ApoE Genotype on Lipid Profile Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 133 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Isasi, S. Shea, R. J. Deckelbaum, S. C. Couch, T. J. Starc, J. D. Otvos, and L. Berglund Apolipoprotein epsilon 2 Allele Is Associated With an Anti-atherogenic Lipoprotein Profile in Children: The Columbia University BioMarkers Study Pediatrics, September 1, 2000; 106(3): 568 - 575. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. Hirono, M. Yasuda, S. Tanimukai, H. Kitagaki, and E. Mori Effect of the Apolipoprotein E {epsilon}4 Allele on White Matter Hyperintensities in Dementia Stroke, June 1, 2000; 31(6): 1263 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ilveskoski, M. Perola, T. Lehtimaki, P. Laippala, V. Savolainen, J. Pajarinen, A. Penttila, K. H. Lalu, A. Mannikko, K. K. Liesto, et al. Age-Dependent Association of Apolipoprotein E Genotype With Coronary and Aortic Atherosclerosis in Middle-Aged Men : An Autopsy Study Circulation, August 10, 1999; 100(6): 608 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. R. Kardia, M. B. Haviland, R. E. Ferrell, and C. F. Sing The Relationship Between Risk Factor Levels and Presence of Coronary Artery Calcification is Dependent on Apolipoprotein E Genotype Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 427 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang, X. Q. Liu, S. C. Rall Jr., and R. W. Mahley Apolipoprotein E2 Reduces the Low Density Lipoprotein Level in Transgenic Mice by Impairing Lipoprotein Lipase-mediated Lipolysis of Triglyceride-rich Lipoproteins J. Biol. Chem., July 10, 1998; 273(28): 17483 - 17490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Raiha, J. Marniemi, P. Puukka, T. Toikka, C. Ehnholm, and L. Sourander Effect of Serum Lipids, Lipoproteins, and Apolipoproteins on Vascular and Nonvascular Mortality in the Elderly Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1224 - 1232. [Abstract] [Full Text]
|
|
|
|
|
|
L. Cattin, M. Fisicaro, M. Tonizzo, M. Valenti, G.M. Danek, M. Fonda, P.G. Da Col, S. Casagrande, E. Pincetti, M. Bovenzi, et al. Polymorphism of the Apolipoprotein E Gene and Early Carotid Atherosclerosis Defined by Ultrasonography in Asymptomatic Adults Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 91 - 94. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kalmijn, E.J.M. Feskens, L.J. Launer, and D. Kromhout Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly Men Stroke, December 1, 1996; 27(12): 2230 - 2235. [Abstract] [Full Text]
|
|
|
|
|
|
P. W.F. Wilson, E. J. Schaefer, M. G. Larson, and J. M. Ordovas Apolipoprotein E Alleles and Risk of Coronary Disease: A Meta-analysis Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1250 - 1255. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Terry, G. Howard, M. Mercuri, M. G. Bond, and J. R. Crouse III Apolipoprotein E Polymorphism Is Associated With Segment-Specific Extracranial Carotid Artery Intima-Media Thickening Stroke, October 1, 1996; 27(10): 1755 - 1759. [Abstract] [Full Text]
|
|
|
|
|
|
H. Basun, E.H. Corder, Z. Guo, L. Lannfelt, L.S. Corder, K.G. Manton, B. Winblad, and M. Viitanen Apolipoprotein E Polymorphism and Stroke in a Population Sample Aged 75 Years or More Stroke, August 1, 1996; 27(8): 1310 - 1315. [Abstract] [Full Text]
|
|
|
|
|
|
J. Kuusisto, L. Mykkanen, K. Kervinen, Y. A. Kesaniemi, and M. Laakso Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1280 - 1286. [Abstract] [Full Text]
|
|
|
|
|
|
J. H. Stengard, K. E. Zerba, J. Pekkanen, C. Ehnholm, A. Nissinen, and C. F. Sing Apolipoprotein E Polymorphism Predicts Death From Coronary Heart Disease in a Longitudinal Study of Elderly Finnish Men Circulation, January 15, 1995; 91(2): 265 - 269. [Abstract] [Full Text]
|
|
|
|
|
|
P. W. F. Wilson, R. H. Myers, M. G. Larson, J. M. Ordovas, P. A. Wolf, and E. J. Schaefer Apolipoprotein E Alleles, Dyslipidemia, and Coronary Heart Disease: The Framingham Offspring Study JAMA, December 7, 1994; 272(21): 1666 - 1671. [Abstract] [PDF]
|
|